Therapie der postoperativen Endophthalmitis

Standard

Therapie der postoperativen Endophthalmitis : Operieren oder nur injizieren? / Mautone, L; Skevas, C; Spitzer, M S.

in: OPHTHALMOLOGE, Jahrgang 118, Nr. 3, 03.2021, S. 219-229.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ReviewForschung

Harvard

APA

Vancouver

Bibtex

@article{f41ae73daf2b45cfa97b4f7326d4e5fa,
title = "Therapie der postoperativen Endophthalmitis: Operieren oder nur injizieren?",
abstract = "BACKGROUND: Postoperative endophthalmitis is among the most feared complications encountered after intraocular surgery. A prompt diagnosis and initiation of treatment are crucial for the visual prognosis, which also depends on the causative microorganism. Despite advances in prevention and the availability of more epidemiological data, most of the evidence for treatment dates back to a single study, the early vitrectomy study (EVS) carried out in the early 1990s. The EVS showed that vitrectomy with intravitreal antibiotics was superior to intravitreal antibiotics alone, only when visual acuity was light perception or below. The addition of systemic antibiotics did not have any benefits. Over the last 30 years, however, surgical techniques have continued to evolve and the medicinal options have also been expanded. Moreover, the EVS examined only endophthalmitis after cataract surgery and strictly speaking the results cannot be transferred to endophthalmitis from other causes.OBJECTIVE: This review discusses the current evidence for the different treatment modalities of the most important types of postoperative endophthalmitis.CONCLUSION: The EVS provided important guidelines for the initial management of endophthalmitis and these guidelines remain relevant to this day; however, in view of the refinement of surgical techniques, novel treatment options, especially the nowadays continuously growing number of intravitreal injections and even some new antibiotics, it would be desirable if new controlled trials addressing the treatment of endophthalmitis would be performed.",
keywords = "Anti-Bacterial Agents/therapeutic use, Cataract Extraction, Endophthalmitis/diagnosis, Eye Infections, Bacterial/drug therapy, Humans, Intravitreal Injections, Postoperative Complications/drug therapy, Retrospective Studies, Vitrectomy",
author = "L Mautone and C Skevas and Spitzer, {M S}",
year = "2021",
month = mar,
doi = "10.1007/s00347-021-01320-9",
language = "Deutsch",
volume = "118",
pages = "219--229",
journal = "OPHTHALMOLOGE",
issn = "0941-293X",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Therapie der postoperativen Endophthalmitis

T2 - Operieren oder nur injizieren?

AU - Mautone, L

AU - Skevas, C

AU - Spitzer, M S

PY - 2021/3

Y1 - 2021/3

N2 - BACKGROUND: Postoperative endophthalmitis is among the most feared complications encountered after intraocular surgery. A prompt diagnosis and initiation of treatment are crucial for the visual prognosis, which also depends on the causative microorganism. Despite advances in prevention and the availability of more epidemiological data, most of the evidence for treatment dates back to a single study, the early vitrectomy study (EVS) carried out in the early 1990s. The EVS showed that vitrectomy with intravitreal antibiotics was superior to intravitreal antibiotics alone, only when visual acuity was light perception or below. The addition of systemic antibiotics did not have any benefits. Over the last 30 years, however, surgical techniques have continued to evolve and the medicinal options have also been expanded. Moreover, the EVS examined only endophthalmitis after cataract surgery and strictly speaking the results cannot be transferred to endophthalmitis from other causes.OBJECTIVE: This review discusses the current evidence for the different treatment modalities of the most important types of postoperative endophthalmitis.CONCLUSION: The EVS provided important guidelines for the initial management of endophthalmitis and these guidelines remain relevant to this day; however, in view of the refinement of surgical techniques, novel treatment options, especially the nowadays continuously growing number of intravitreal injections and even some new antibiotics, it would be desirable if new controlled trials addressing the treatment of endophthalmitis would be performed.

AB - BACKGROUND: Postoperative endophthalmitis is among the most feared complications encountered after intraocular surgery. A prompt diagnosis and initiation of treatment are crucial for the visual prognosis, which also depends on the causative microorganism. Despite advances in prevention and the availability of more epidemiological data, most of the evidence for treatment dates back to a single study, the early vitrectomy study (EVS) carried out in the early 1990s. The EVS showed that vitrectomy with intravitreal antibiotics was superior to intravitreal antibiotics alone, only when visual acuity was light perception or below. The addition of systemic antibiotics did not have any benefits. Over the last 30 years, however, surgical techniques have continued to evolve and the medicinal options have also been expanded. Moreover, the EVS examined only endophthalmitis after cataract surgery and strictly speaking the results cannot be transferred to endophthalmitis from other causes.OBJECTIVE: This review discusses the current evidence for the different treatment modalities of the most important types of postoperative endophthalmitis.CONCLUSION: The EVS provided important guidelines for the initial management of endophthalmitis and these guidelines remain relevant to this day; however, in view of the refinement of surgical techniques, novel treatment options, especially the nowadays continuously growing number of intravitreal injections and even some new antibiotics, it would be desirable if new controlled trials addressing the treatment of endophthalmitis would be performed.

KW - Anti-Bacterial Agents/therapeutic use

KW - Cataract Extraction

KW - Endophthalmitis/diagnosis

KW - Eye Infections, Bacterial/drug therapy

KW - Humans

KW - Intravitreal Injections

KW - Postoperative Complications/drug therapy

KW - Retrospective Studies

KW - Vitrectomy

U2 - 10.1007/s00347-021-01320-9

DO - 10.1007/s00347-021-01320-9

M3 - SCORING: Review

C2 - 33566160

VL - 118

SP - 219

EP - 229

JO - OPHTHALMOLOGE

JF - OPHTHALMOLOGE

SN - 0941-293X

IS - 3

ER -